A general synthetic route to a novel type of fairly stable heteroazulene analogues of triphenylmethyl cations, tris(2-oxo-2H-cyclohepta[b]furan-3-yl)-, tris(1,2-dihydro-2-oxo-N-phenylcyclohepta[b]pyrrol-3-yl)-, and tris(1,2-dihydro-N-methyl-2-oxocyclohepta[b]pyrrol-3-yl)methyl cations, 4a–c, is reported. The synthetic method is based on a simple, TFA-catalyzed electrophilic aromatic substitution on the heteroazulenes 2H-cyclohepta[b]furan-2-one and 1,2-dihydro-N-phenyl-2H-, and 1,2-dihydro-N-methyl-2H-cyclohepta[b]pyrrol-2-one with trimethyl orthoformate, followed by oxidative hydrogen abstraction with DDQ and subsequent exchange of the counter-anion by using aq. HPF6 solution. The stability of the cations 4a–c is expressed as the pKR+-value, which is determined spectrophotometrically as 9.7, 12.2, and 13.1, respectively. The electrochemical reduction of 4a–c exhibits reversible waves and low reduction potentials at −0.31, −0.58, and −0.62 (V vs. Ag/Ag+) upon cyclic voltammetry (CV), which values are lower than that of tri(azulen-1-yl)methyl cations.
No takes yet. Share an insight, caveat, or question.
Naya et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: